Defining the risk of SARS-CoV-2 variants on immune protection-Reference-Cited by-同舟云学术

Defining the risk of SARS-CoV-2 variants on immune protection

Published:2022-03-31 Issue:7911 Volume:605 Page:640-652
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

DeGrace Marciela M.,Ghedin Elodie^ORCID,Frieman Matthew B.^ORCID,Krammer Florian^ORCID,Grifoni Alba^ORCID,Alisoltani Arghavan,Alter Galit^ORCID,Amara Rama R.^ORCID,Baric Ralph S.^ORCID,Barouch Dan H.^ORCID,Bloom Jesse D.^ORCID,Bloyet Louis-Marie^ORCID,Bonenfant Gaston,Boon Adrianus C. M.^ORCID,Boritz Eli A.,Bratt Debbie L.^ORCID,Bricker Traci L.,Brown Liliana,Buchser William J.^ORCID,Carreño Juan Manuel,Cohen-Lavi Liel^ORCID,Darling Tamarand L.,Davis-Gardner Meredith E.,Dearlove Bethany L.^ORCID,Di Han,Dittmann Meike,Doria-Rose Nicole A.,Douek Daniel C.,Drosten Christian^ORCID,Edara Venkata-Viswanadh^ORCID,Ellebedy Ali^ORCID,Fabrizio Thomas P.^ORCID,Ferrari Guido,Fischer Will M.,Florence William C.,Fouchier Ron A. M.^ORCID,Franks John,García-Sastre Adolfo^ORCID,Godzik Adam^ORCID,Gonzalez-Reiche Ana Silvia^ORCID,Gordon Aubree^ORCID,Haagmans Bart L.^ORCID,Halfmann Peter J.,Ho David D.^ORCID,Holbrook Michael R.^ORCID,Huang Yaoxing^ORCID,James Sarah L.^ORCID,Jaroszewski Lukasz,Jeevan Trushar,Johnson Robert M.^ORCID,Jones Terry C.^ORCID,Joshi Astha^ORCID,Kawaoka Yoshihiro^ORCID,Kercher Lisa^ORCID,Koopmans Marion P. G.^ORCID,Korber Bette^ORCID,Koren Eilay,Koup Richard A.,LeGresley Eric B.^ORCID,Lemieux Jacob E.,Liebeskind Mariel J.^ORCID,Liu Zhuoming^ORCID,Livingston Brandi,Logue James P.^ORCID,Luo Yang^ORCID,McDermott Adrian B.^ORCID,McElrath Margaret J.,Meliopoulos Victoria A.^ORCID,Menachery Vineet D.^ORCID,Montefiori David C.,Mühlemann Barbara,Munster Vincent J.^ORCID,Munt Jenny E.,Nair Manoj S.^ORCID,Netzl Antonia^ORCID,Niewiadomska Anna M.,O’Dell Sijy,Pekosz Andrew^ORCID,Perlman Stanley^ORCID,Pontelli Marjorie C.,Rockx Barry^ORCID,Rolland Morgane^ORCID,Rothlauf Paul W.^ORCID,Sacharen Sinai,Scheuermann Richard H.^ORCID,Schmidt Stephen D.,Schotsaert Michael^ORCID,Schultz-Cherry Stacey^ORCID,Seder Robert A.^ORCID,Sedova Mayya,Sette Alessandro,Shabman Reed S.^ORCID,Shen Xiaoying,Shi Pei-Yong^ORCID,Shukla Maulik,Simon Viviana^ORCID,Stumpf Spencer,Sullivan Nancy J.,Thackray Larissa B.^ORCID,Theiler James,Thomas Paul G.^ORCID,Trifkovic Sanja^ORCID,Türeli Sina^ORCID,Turner Samuel A.,Vakaki Maria A.,van Bakel Harm^ORCID,VanBlargan Laura A.^ORCID,Vincent Leah R.^ORCID,Wallace Zachary S.^ORCID,Wang Li,Wang Maple,Wang Pengfei^ORCID,Wang Wei,Weaver Scott C.^ORCID,Webby Richard J.^ORCID,Weiss Carol D.^ORCID,Wentworth David E.^ORCID,Weston Stuart M.^ORCID,Whelan Sean P. J.^ORCID,Whitener Bradley M.^ORCID,Wilks Samuel H.,Xie Xuping^ORCID,Ying Baoling,Yoon Hyejin^ORCID,Zhou Bin,Hertz Tomer^ORCID,Smith Derek J.^ORCID,Diamond Michael S.^ORCID,Post Diane J.^ORCID,Suthar Mehul S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-022-04690-5.pdf

Reference122 articles.

1. Krammer, F. SARS-CoV-2 vaccines in development. Nature 586, 516–527 (2020).

2. Plante, J. A. et al. The variant gambit: COVID-19’s next move. Cell Host Microbe 29, 508–515 (2021).

3. Walensky, R. P., Walke, H. T. & Fauci, A. S. SARS-CoV-2 variants of concern in the United States—challenges and opportunities. JAMA 325, 1037–1038 (2021).

4. Fischer, W. et al. HIV-1 and SARS-CoV-2: patterns in the evolution of two pandemic pathogens. Cell Host Microbe 29, 1093–1110 (2021).

5. Korber, B. et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182, 812–827 (2020). This was the first study showing that a newly emerging mutation in the spike protein could come to rapidly dominate across the globe, indicating a fitness advantage.

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants;Antiviral Research;2024-10

2. Clinical and pathogen features of COVID-19-associated infections during an Omicron strain outbreak in Guangzhou, China;Microbiology Spectrum;2024-09-06

3. Preamplification-free viral RNA diagnostics with single-nucleotide resolution using MARVE, an origami paper-based colorimetric nucleic acid test;Nature Protocols;2024-07-18

4. COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans;JAMA Network Open;2024-07-01

5. Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics;PLOS Computational Biology;2024-06-10